Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy for preventing cardiovascular disease in post-menopausal womenSteroid sex hormones for lower limb atherosclerosisTiming and duration of menopausal hormone treatment may affect cardiovascular outcomesAbdominal aortic aneurysm events in the women's health initiative: cohort studyPrevalence, clinical significance, and management of peripheral arterial disease in women: is there a role for postmenopausal hormone therapy?Steroid sex hormones for lower limb atherosclerosis.Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality.Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative.The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in women.Hormone replacement therapy and peripheral vascular disease in women.Hormone therapy is associated with preserved smooth muscle structure and dilation in the arterial vasculature of the leg in older womenVascular and metabolic effects of sex steroids: new insights into clinical trials.Vascular actions of estrogens: functional implications.Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONERisk factors in abdominal aortic aneurysm and in Polish population aortoiliac occlusive disease and differences between them [corrected].Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study.Identifying abdominal aortic aneurysm risk factors in postmenopausal women.The protective effect of Er-Xian decoction against myocardial injury in menopausal rat model
P2860
Q24187326-31D0F1F6-0A1E-4E39-9FE9-58D8BEDB0C24Q24197712-24F94D6B-B6CB-4689-9C2C-E0C01A9A5C44Q24198081-DE1BCC5F-C351-4C31-9322-FCF08D5C19E3Q24626206-1FE482AB-A63C-4EEC-B25F-E17167353594Q24654790-0A91A5A0-B883-49B7-8D0B-859645E40F1FQ28219238-192C7AAA-190F-423E-B76B-8DD3E335BA60Q33908587-180AEA42-C3A3-4F59-817E-21164AA4867CQ34362281-22E3DC33-D831-46EB-B1B3-0B2BD2B4E426Q34420014-C2ADCF8B-A0D1-4F8F-B5E3-97D2F9B7DC94Q34449454-00D14B25-BC1C-4817-8DC5-5B6C247D641AQ35159382-8D935874-567B-4B98-9A3E-C31FF1F53836Q35981132-22A4FE4C-9B56-4AE9-B7A0-B308A48E0EC4Q36580155-924DAB0A-34CD-428B-8E4B-BC4E412DB20AQ36888620-5E90D407-E4CD-432D-A9D8-D99B683BCEE8Q37088243-D82B07F8-038C-4D77-91CE-980261EC4D77Q37098920-94706ADF-08E4-4116-A80D-20E23E1B1EC4Q37400367-593FFB0D-4AB8-4F07-A66B-D51F177A362BQ48246118-99564105-93FA-431E-BDCB-C002FB5D2AF5Q51666845-37C8F5E8-5DC1-493F-8B8B-7812C975440AQ58768337-140CE7B4-B0A5-4CF8-A4C0-6C9F908C529D
P2860
Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Estrogen plus progestin and th ...... the Women's Health Initiative.
@en
Estrogen plus progestin and th ...... the Women's Health Initiative.
@nl
type
label
Estrogen plus progestin and th ...... the Women's Health Initiative.
@en
Estrogen plus progestin and th ...... the Women's Health Initiative.
@nl
prefLabel
Estrogen plus progestin and th ...... the Women's Health Initiative.
@en
Estrogen plus progestin and th ...... the Women's Health Initiative.
@nl
P2093
P50
P1433
P1476
Estrogen plus progestin and th ...... the Women's Health Initiative.
@en
P2093
Denise E Bonds
Helaine E Resnick
Jane M Kotchen
Judith Hsia
Kamal Masaki
Lawrence S Phillips
Panagiota Caralis
Rebecca J Rodabough
Women's Health Initiative Investigators
P304
P356
10.1161/01.CIR.0000115309.63979.92
P407
P577
2004-02-01T00:00:00Z